Generic Biosimilar Medicines Association

Making Medicines Affordable

  • Home
  • About GBMA
    • Contact us
    • GBMA Members
    • Guiding principles
    • Code of Practice
      • Code Complaint Committee
      • Historical Event Reporting
      • Annual Review
        • 2011
        • 2012
        • 2013
        • 2014
        • 2015
        • 2016
        • 2017
        • 2018
        • 2019
        • 2020
        • 2021
      • Lodging a complaint
    • Media Enquiries
    • Our Objectives
    • Links
  • Advocacy
    • New 5-year Strategic Agreement
    • Extended Strategic Agreement
    • Generic Medicines Working Group (GMWG)
    • Submissions
  • Generics
    • Facts and Fallacies
    • Key Figures on Generic Medicines
    • What is a Generic Medicine?
    • Bioequivalence Explained
  • Biosimilars
    • IGBA Global Biosimilars Week
    • GBMA Position on Biosimilars
      • Impact of Biosimilars
      • Switching
      • Pharmacy Substitution
      • Regulation
      • Awareness and Uptake
      • Naming
    • Key Figures on Biosimilars
  • Topics
    • IGBA
    • Price Disclosure
    • Intellectual Property
    • International Trade Agreements
  • News
    • News 2022
    • News 2021
    • News 2020
    • News 2019
    • News 2018
    • News 2017
    • News 2016
    • News 2015
    • News 2014
  • GBMA Education
  • COVID-19 Virus
    • COVID-19 Virus: The Facts
You are here: Home / Latest news / News 2022 / Health Minister, Greg Hunt MP and Shadow Minister, Mark Butler MP confirmed as VIP speakers at the GBMA Industry Budget Week luncheon

Health Minister, Greg Hunt MP and Shadow Minister, Mark Butler MP confirmed as VIP speakers at the GBMA Industry Budget Week luncheon

March 15, 2022 By Admin

Embargoed until Tuesday March 15, 2022

Canberra, ACT

The peak body for affordable medicines today announced Minister for Health and Aged Care, the Hon Greg Hunt MP and Shadow counterpart, the Hon Mark Butler MP, will join members and industry guests for its annual Budget Week industry luncheon in Parliament House on Thursday March 31, 2022.

Independent Chair of the Generic and Biosimilar Medicines Association (GBMA), Professor Jane Halton AO PSM, today said it was a particularly important event given it was the last budget before the Federal election and the final one for Mr Hunt, who is retiring from politics.

As Australia begins to emerge from the economic and health ravages of the pandemic, the national health budget is under unprecedented pressure. GBMA will continue to work closely with both parties to ensure effective policies are developed that not only provide greater health outcomes for Australians but that also ensure the overwhelmed health budget can be repaired and stabilised.

“We know the last year has been particularly tough for many Australians, particularly those most vulnerable, and our priority has been to ensure every Australian can continue to have equitable and affordable access to safe medicines,” said Prof. Halton.

“A key focus for the GBMA in 2022 will be to help the next Government implement policy levers that help drive the uptake of biosimilars,” Prof. Halton said. “Biosimilars will offset the cost of the innovative but expensive biologic treatments that the Government is under pressure to subsidise.”

The CEO of the GBMA, Ms Marnie Peterson, said this year also marked the start of the sector’s five-year Strategic Agreement that would also see GBMA members invest in supply and infrastructure that would allow them to increase their stockholdings of medicines to four and six months.

“We are doing everything we can to ensure Australians are protected against international supply chain shocks,” Ms Peterson said. “Whilst at the same time, we are creating that all important fiscal headroom on the PBS that allows greater access to new medicines.

Having a workable balance between biologic medicines and their biosimilar equivalents will be key to create a sustainable platform for the PBS.”

Ms Peterson said that the GBMA looks forward to hosting Mr Hunt during his last budget week ever as a Minister and Mr Butler, on the same day as the Opposition’s Budget Reply.

“The GBMA stands ready to work with the next Government to ensure the needs of the Australian patient continues to be prioritised.” ENDS

NB: Media are invited to attend the luncheon on Thursday, March 31. Mural Hall. For further details, please RSVP to barbara.bazarnik@gbma.com.au.

–ENDS–

Media inquiries:
Jannette Cotterell
Executive Counsel Australia
0419 204 059
jcotterell@executivecounsel.com.au

 

ABOUT GBMA

The Generic and Biosimilar Medicines Association (GBMA) is the peak representative body of generic and biosimilar medicine suppliers in Australia. Its members ensure that all Australians are offered high quality generic and biosimilar medicines, whilst providing affordable community health outcomes that benefit all Australians.

For more information, please contact the GBMA – admin@gbma.com.au or visit www.gbma.com.au

Filed Under: News 2022

Our Members

logo_ACCORD
logo_ACCORD
Organon logo
Organon logo
Juno
Juno
Sandoz logo
Sandoz logo
Viatris
Viatris
Arrow logo
Arrow logo
apotex
apotex
Celltrion Healthcare
Celltrion Healthcare
Fresnius Kabi
Fresnius Kabi
Fresnius Kabi
commercial_eyes
commercial_eyes
sinapse
sinapse

Generic Medicines: The Facts

Generic Medicines Facts

Generic medicines are quality medicines at affordable prices. Ask your doctor to prescribe a generic medicine, or ask for a generic medicine next time you take your prescription to the pharmacy. … More…

The promise of Biosimilars

Biosimilars

https://youtu.be/sBDur7xa084   Biosimilars provide a unique opportunity to help manage the growing costs of biological medicines on the PBS. They offer therapeutically equivalent and … More…

Health Minister, Greg Hunt MP and Shadow Health Minister, Mark Butler MP both applaud the role of the GBMA Strategic Agreement for the security of the supply of vital medicines

April 1, 2022

Friday March 1, 2022 Canberra, ACT In one of his last speeches in Parliament as the … More...

Australia’s peak body for affordable medicines welcomes a new board member

February 15, 2022

Embargoed until Tuesday February 15, 2022 Canberra, … More...

GBMA welcomes new member at a critical time in medicine policy

February 10, 2022

Embargoed until Thursday February 10, 2022 Canberra, … More…

© 2022 Generic Medicines Industry Association Pty Ltd | Site Map | Contact Us